$CAPR
+400%
Capricor Therapeutics
Biotechnology
FDA Catalyst
Swing Trade
Why We Alerted
CAPR was identified as a high-potential biotechnology play ahead of a key FDA-related data release with favorable technical structure.
News & Catalyst
Positive FDA-related data release triggered immediate market response.
Our Analysis
<p>This trade exemplifies the power of catalyst-driven biotech plays when proper risk management is applied. The technical setup showed accumulation patterns before the FDA announcement, signaling institutional interest. A 400% gain in 7 days demonstrates why biotech catalysts remain one of the most explosive trading opportunities.</p>
Trade Details
Alert Date
11/1/2024Entry Price
$2.50Exit Price
$12.50Profit/Share
+$10.00Profit Date
11/8/2024Time to Profit
7 daysAnalyst
Rama
View all analyses →